Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 24 (5) , 331-344
- https://doi.org/10.1016/s0305-7372(98)90056-1
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumoursBritish Journal of Cancer, 1996
- Mechanisms of DNA Excision RepairScience, 1994
- Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.Journal of Clinical Investigation, 1994
- Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assayCancer, 1994
- Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryCarcinogenesis: Integrative Cancer Research, 1991
- Characterization of the DNA damage recognized by the antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNACarcinogenesis: Integrative Cancer Research, 1990
- The measurement of cisplatin-DNA adduct levels in testicular cancer patientsCarcinogenesis: Integrative Cancer Research, 1988
- Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?Mutation Research Letters, 1987
- Molecular characterization of the human excision repair gene : cDNA cloning and amino acid homology with the yeast DNA repair geneCell, 1986
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Journal of Clinical Investigation, 1986